Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Influx Healthtech Ltd. Share Price
Day's Range
Day's Range
Low
₹240.00
High
₹250.00
Price Summary
| Previous Close | ₹242.95 |
|---|---|
| Day's Range | ₹240.00 - ₹250.00 |
| Open | ₹245.00 |
| 52 Week Range | ₹120.00 - ₹298.75 |
| Volume | 21,600 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 52.48 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 27.32 |
| TTM EPS (₹) | 8.87 |
| P/E Ratio | |
| Book Value(₹) | 0.00 |
| PAT Margin (%) | |
| Face Value (₹) | 10.00 |
| ROCE(%) |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 1048.54 |
| Expenses | N/A | N/A |
| PBT | N/A | 177.14 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 132.73 |
About Influx Healthtech Ltd.
| Founded | 2020 |
|---|---|
| Managing Director | Munir Abdul Ganee Chandniwala |
| NSE Symbol | INFLUX |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,36,666.97 | 1,818.60 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,76,804.73 | 6,650.80 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,50,554.07 | 4,429.60 | 3,140.10 - 3,140.10 |
| Apollo Hospitals Enterprise Ltd. | 1,21,241.38 | 8,408.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,09,119.71 | 1,350.25 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,06,811.74 | 1,068.15 | 835.50 - 835.50 |
| Dr. Reddy's Laboratories Ltd. | 1,05,919.50 | 1,262.15 | 1,148.40 - 1,148.40 |
| Lupin Ltd. | 1,03,645.47 | 2,294.10 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 99,869.41 | 1,083.05 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 97,611.60 | 2,385.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Ajanta Pharma informs about annual report
Ajanta Pharma has informed that the Forty-Seventh Annual General Meeting (‘AGM’) of the Company will be held on Thursday, 16th July 2026 at 11.00 am through Video Conferencing (‘VC’)/ Other Audio-Visual Means (‘OAVM’). Pursuant to Regulation 34(1) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has submitted the Annual Report and Business Responsibility & Sustainability Report of the Company for the financial year 2025-26 along with Notice of the AGM. The Annual report, Business Responsibility & Sustainability Report and the Notice of AGM are being sent through electronic mode to members whose e-mails ids are registered and the same are also uploaded on the Company's website https://www.ajantapharma.com/assets/frontend/images/investors/files/annual_results/178175 8151_AjantaPharma-AR-2025-26.pdf. Letter containing the QR code & path/web-link to access Annual Report will be sent to those shareholders who have not registered their email IDs with the Company/ Depositories/ Registrar and Share Transfer Agent.
The above information is a part of company’s filings submitted to BSE.
Procter & Gamble Health submits presentation
HealthCare Global Enterprises informs about updates
Hannah Joseph Hospital informs about annual report
Fermenta Biotech informs about investor meeting
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Fermenta Biotech has informed that the Company, through its officials, will be participating in meeting(s) with investors on June 22, 2026 in Mumbai (One-to-one). The company has further informed that the Press Release dated May 26, 2026 regarding audited Financial results for the year ended March 31, 2026 and relevant Investor Presentation proposed to be discussed with investor(s) in the above interaction is uploaded on the website of the Company: www.fermentabiotech.com and on BSE’ website: www.bseindia.com. No unpublished price sensitive information (UPSI) is intended to be discussed during the interaction.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Influx Healthtech Ltd. is ₹242.95 as of 2026-06-18.
The market capitalisation of Influx Healthtech Ltd. is ₹561.05 as of 2026-06-17.
The 1-year return of Influx Healthtech Ltd. is 0.60% as of 2026-06-18.
The P/E ratio of Influx Healthtech Ltd. is 0.00 as of 2026-06-18.
The 52-week high and low of Influx Healthtech Ltd. are ₹298.75 and ₹120.00, respectively, as of 2026-06-18.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
